4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-010882
CEO and CFO bought 1,500 shares at $17.68 ($26,520)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-03-20 | Purchase | +1,500 | $17.68 | $26,520 | 5,345,277 | D |
| Open-market purchases · 1,500 sh · avg $17.68 · $26,520 | |||||||
Loading xslF345X05/ownership.xml…